Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inhibrx Biosciences

14.39
+0.47003.38%
Post-market: 14.390.00000.00%16:20 EDT
Volume:81.68K
Turnover:1.16M
Market Cap:208.31M
PE:0.13
High:14.55
Open:13.96
Low:13.26
Close:13.92
Loading ...
May 09, 2022

Major Issues Report

8-K - Current report
Apr 25, 2022

Major Issues Report

8-K - Current report
Apr 05, 2022

Major Issues Report

8-K - Current report
Apr 04, 2022

Major Issues Report

8-K - Current report
Mar 03, 2022

Major Issues Report

8-K - Current report
Mar 02, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 22, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2022

Major Issues Report

8-K - Current report
Jan 04, 2022

Major Issues Report

8-K - Current report
Dec 01, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2021

Major Issues Report

8-K - Current report